GLOW vs KLOW: the short answer
KLOW holds the three peptides in GLOW (BPC-157, TB-500 and GHK-Cu) plus a fourth, KPV. Glow Peptides states GLOW at 70 mg in total across its three components and KLOW at 80 mg in total across its four, each freeze-dried as one solid in a sealed vial. Neither is ranked above the other; both are for laboratory research use only.
- GLOW: BPC-157, TB-500 and GHK-Cu, 70 mg in total per vial, vial code GL70. Defined in What is GLOW peptide? and listed on the GLOW Blend product page.
- KLOW: BPC-157, TB-500, GHK-Cu and KPV, 80 mg in total per vial, vial code KL80. Defined in What is KLOW peptide? and listed on the KLOW Blend product page.
- The same for both: one co-lyophilized solid per vial, a catalog purity specification of 99.2% or higher per component by HPLC, and certificates issued by Freedom Diagnostics, an independent U.S. laboratory.
- Different: KPV, the stated total, the catalog code and the number of components a matching certificate names.
GLOW vs KLOW: the head-to-head table
GLOW and KLOW differ in composition and in what follows from it: KLOW has one more component (KPV), a higher stated total, its own catalog codes and its own lots. The format, the purity specification, the laboratory and the intended use are the same for both.
| Property | GLOW | KLOW |
|---|---|---|
| Components by name | BPC-157, TB-500, GHK-Cu | BPC-157, TB-500, GHK-Cu, KPV |
| Number of components | Three | Four |
| Stated total per vial | 70 mg across the three | 80 mg across the four |
| Vial catalog code | GL70 | KL80 |
| Format | One co-lyophilized solid in a sealed vial | One co-lyophilized solid in a sealed vial |
| Capsule product of the same name | GLOW Blend Capsules, code GL70-C | KLOW Blend Capsules, code KL80-C |
| Catalog purity specification | 99.2% or higher per component by HPLC | 99.2% or higher per component by HPLC |
| Laboratory on the worked certificate | Freedom Diagnostics, an independent U.S. laboratory | Freedom Diagnostics, an independent U.S. laboratory |
| Worked lot on this page | 260402HPGL70 | 260320HPKL80 |
| Names a matching certificate lists | GHK-Cu, BPC-157, thymosin beta-4 | GHK-Cu, KPV, BPC-157, thymosin beta-4 |
| Intended use | Laboratory research only; not for human or veterinary use | Laboratory research only; not for human or veterinary use |
Both totals describe the whole vial, and this page gives each blend by its total alone. What the 70 mg and 80 mg printed on each label measure is covered in GLOW 70 mg vs KLOW 80 mg.
What does KPV add to KLOW?
KPV is the fourth component and the only one KLOW has that GLOW lacks. It is the tripeptide lysine-proline-valine (Lys-Pro-Val), the sequence found at residues 11 to 13 of alpha-melanocyte-stimulating hormone. PubChem holds it under CID 125672 with the title Msh (11-13), so the record number is a better search key than the three letters.
In the documentation, KPV adds one more name for a laboratory to find: a KLOW certificate should list it in the identity line, and a GLOW certificate should not. This page describes KPV by identity only and says nothing about what it does. Its registry details are in the KPV reference guide and the KPV chemical identifiers page.
Is one blend better than the other?
Neither GLOW nor KLOW is ranked above the other, because no ranking follows from their composition. KLOW lists one more component and carries a higher stated total, and that is a difference in what the vial holds, not in quality or suitability. A longer list gives a laboratory one more identity to document and one more variable to account for in a study design; it does not make the four-component blend a stronger or more complete material.
Both blends stand on the same documentation footing: the same basis for the purity specification, the same laboratory on the worked certificates and the same lot-by-lot reporting. For a particular vial of either blend, the paperwork that matters is the certificate for its lot.
When would a laboratory pick GLOW or KLOW?
A laboratory picks by the component list its study design names, then checks the paperwork for the lot it would receive.
| If the study design calls for | Fits | What to check first |
|---|---|---|
| BPC-157, TB-500 and GHK-Cu with no KPV present | GLOW | The certificate names three components and no KPV |
| BPC-157, TB-500, GHK-Cu and KPV together | KLOW | The certificate names all four, KPV included |
| A capsule rather than a vial | GLOW Blend Capsules or KLOW Blend Capsules | The capsule product's own composition statement and lot record |
Glow Peptides supplies both blends to qualified researchers, laboratories and institutions for in-vitro work. It gives no clinical, administration or human-use guidance for either one, and nothing on this page recommends a blend for any purpose outside the laboratory.
How do you read a GLOW certificate and a KLOW certificate?
Read a GLOW certificate and a KLOW certificate the same way and expect one difference: a GLOW report lists three components and a KLOW report lists four. The worked examples are the certificates for GLOW lot 260402HPGL70 and KLOW lot 260320HPKL80, both issued by Freedom Diagnostics.
| Printed field | GLOW lot 260402HPGL70 | KLOW lot 260320HPKL80 |
|---|---|---|
| Lot as printed | 260402-HP-GL70-01 | 260320-HP-KL80-01 |
| Product line | GLOW, 70 mg | KLOW, 80 mg |
| Identity line | GHK-Cu, BPC-157, thymosin beta-4 | GHK-Cu, KPV, BPC-157, thymosin beta-4 |
| Accession number | 2604080079 | 2603230231 |
| Search code | Glow2604080079 | Glow2603230231 |
| Reported | April 9, 2026 | March 24, 2026 |
| Stated method | HPLC with UV detection coupled with mass spectrometry | HPLC with UV detection coupled with mass spectrometry |
| Endotoxin | Two replicates, each reported as Pass | Two replicates, each reported as Pass |
- Pair the lot. Start from the Quality and COA directory, which pairs each listed vial lot with its report. Ignore hyphens only. The directory pairs 260402HPGL70 with 260402-HP-GL70-01 and 260320HPKL80 with 260320-HP-KL80-01; that explicit pairing, not a reading of the trailing 01, is what ties each report to its lot. Glow's guide to lot numbers explains the segments. If the strings differ in any other way, ask Glow Peptides to confirm the pairing before using the report.
- Check the product line and its total. GLOW with 70 mg, or KLOW with 80 mg. A report whose product line names the other blend belongs to a different material.
- Count the names in the identity line. Three for GLOW and four for KLOW, with KPV on the KLOW report only. TB-500 appears as thymosin beta-4 on both.
- Keep the purity figure with its method. Record the purity wording, value and method exactly as the report prints them, and keep the catalog purity specification of 99.2% or higher per component as a separate line.
- Look the report up. Type the search code, or the accession number, into the laboratory's COA Look Up and compare its record with the copy you hold.
A certificate is the laboratory's report on the sample it received, as of its reported date. Glow Peptides links each report as the laboratory issued it; the findings in it are the laboratory's. The general method is in how to read a Certificate of Analysis, and the laboratory lookup is set out in how to verify a Freedom Diagnostics certificate.
Which products carry the GLOW and KLOW names?
Four Glow Peptides products carry the GLOW and KLOW names. The GLOW vial (GL70) and the KLOW vial (KL80) are the lyophilized blends compared on this page. GLOW Blend Capsules (GL70-C) and KLOW Blend Capsules (KL80-C) are separate products, each with its own composition statement and its own lot records.
A vial certificate therefore does not describe a capsule lot, and a capsule certificate does not describe a vial. When a search result or a forum post says GLOW or KLOW without naming the product, the catalog code on the product page (GL70, KL80, GL70-C or KL80-C) tells the four apart.
What does the purity specification tell you?
GLOW and KLOW share one catalog purity specification, 99.2% or higher per component by HPLC, and a specification is the standard a lot is meant to meet. A certificate reports what the laboratory measured on the sample it received. Record the purity figure exactly as the report prints it, next to its method, and keep it apart from the catalog specification.
The two numbers answer different questions, so neither stands in for the other. FDA's ICH Q2(R2) guidance on validating analytical procedures separates identification, impurity and assay purposes, and a method supports only the question it was validated for. Endotoxin limits follow their own procedures under FDA's Q6A specifications guidance; they do not follow from a purity percentage.
What neither blend is
GLOW and KLOW are research reference materials. Neither is a drug, a dietary supplement, a cosmetic or a medical device, the FDA has not evaluated either one, and neither is for human or veterinary use. Published work on a single component, KPV or GHK-Cu included, does not describe a co-lyophilized blend, and this page compares composition and documentation only, never effects.
Each product page shows the current listing, the stated total and the lot certificates for that blend.
View GLOW Blend on the store → View KLOW Blend on the store →Frequently asked questions about GLOW vs KLOW
What is the difference between GLOW and KLOW?
KLOW contains KPV in addition to the three components of GLOW: BPC-157, TB-500 and GHK-Cu. GLOW is stated at 70 mg in total per vial and KLOW at 80 mg in total; both are co-lyophilized research blends in a sealed vial.
Is KLOW better than GLOW?
Neither is ranked. The two blends differ in composition and in what a matching certificate must name: three components for GLOW, four for KLOW. A laboratory picks the blend whose component list matches its study design.
Does KLOW contain everything in GLOW?
By component name, yes. KLOW lists BPC-157, TB-500 and GHK-Cu, the three GLOW components, and adds KPV. Each blend is stated as one total for the whole vial: 70 mg for GLOW and 80 mg for KLOW.
How is purity reported for a blend?
Read the exact report. The catalog specifies 99.2% or higher per component by HPLC. For a particular lot, record the purity wording and value exactly as printed on its certificate, together with the method and sample identification.
How can I tell a GLOW certificate from a KLOW certificate?
Check the product line and the identity line. A GLOW report names GLOW, 70 mg and three components; a KLOW report names KLOW, 80 mg and four components, KPV among them. The lot number carries GL70 or KL80 to match.
Are GLOW and KLOW for human or veterinary use?
No. Both are supplied only for laboratory research by qualified researchers, laboratories and institutions, and neither is for human or veterinary use. Glow Peptides gives no human-use guidance for either blend.
Sources
- PubChem compound record: Msh (11-13), the KPV tripeptide, CID 125672
- PubChem compound record: BPC-157, CID 9941957
- PubChem compound record: glycyl-L-histidyl-L-lysine (GHK), CID 73587
- NCBI Gene: TMSB4X, thymosin beta 4 X-linked, Gene ID 7114
- PubMed 13451616: Harris and Lerner (1957), alpha-MSH amino acid sequence
- PubMed 6940133: Low, Hu and Goldstein (1981), bovine thymosin beta 4 sequence
- U.S. Food and Drug Administration: Q2(R2) Validation of Analytical Procedures
- U.S. Food and Drug Administration: Q6A Specifications, Test Procedures and Acceptance Criteria
- Freedom Diagnostics: laboratory site, with the COA Look Up
